Blood Group Typing Market: Contours of Evolution and Scope

A wide range of tests finds clinical application in blood group typing—there are as many as 33 blood group systems. Quite wide array of techniques and instruments have become popular in cross-matching tests in transfusion medicine. Transfusion-related problems have opened market for new tests for ABO and Rhesus system. These systems aside, a significant number of genetically-different BGs have been identified.

A growing body of research in blood group typing market has also put a slant emphasis on diseases RBC surface antigens can cause. Constant progress that blood transfusion medicine has witnessed world over is testimony to the growing application of conventional as well as some modern tests in blood group typing market. These comprise antibody screening, cross matching test, HLA typing, and antigen typing.

blood-group-typing-market-2018-2026.jpg

Unarguably, experts consider blood group-linked diseases to be at nascent stage but strikingly evolving. These has attract attention of clinicians in using blood group typing tests for understanding malignancies with chronic diseases. This is a key driver for growing clinical role of ABO blood groups in understanding the severity of infection in chronic diseases. Most importantly, industry players are putting stakes on instruments that are used in blood group typing market, and harness them for expanding the management avenue for cancer.

Blood Group Typing Market: Valuation and Projection

The global blood group typing market stood at US$ 1,500.0 Mn in 2017 and is anticipated to reach US$ 3,556.0 Mn by 2026, expanding at an impressive CAGR of 10.3% from 2018 to 2026.

Blood group typing tests and consumables have gained clinical acceptance due to rise in increase in blood transfusion rate across the world. To a great deal, the need for transfusion processes has risen at rapid pace due to its correlation with hospitalization caused due to various chronic diseases, such as kidney ailments.

The report segments the blood group typing market on the basis of product, technique, test, and end use.

Major end uses comprise instruments, consumables, and services.

PCR-based Techniques Gathered Steam for Blood Grouping for Chronic Diseases

Of all products, consumables accounted for the leading share in 2017 and is expected to retain its lead throughout the forecast period. Constant efforts by researchers to test advanced instruments and kits have helped boost the prominence of the segment. Advancements in analytical devices have bolstered the prospects. Further, rise in demand for molecular diagnostic test kits and reagents

Key techniques used in the blood are PCR-based, microarray-based, assay-based technique, and massively parallel techniques.

Of these, the PCR-based segment held the leading share in the global market in 2017. It is expected to retain its dominance in coming years as well. The segment is expected to clock a CAGR of 10.6% from 2018 to 2026.

PCR-based techniques have gathered steam for blood grouping for chronic diseases such as aplastic anemia, sickle cell anemia, traumatic injuries, and leukemia. The associated techniques are also useful in rare type of blood group. The second prominent share is held by microarray-based segment.

Assay-based technique and massively parallel techniques held an approximately 30.0% share of the global blood group typing market, vis-à-vis revenue, in 2017.

In coming years, portable blood typing methods will help save the lives of patients who need blood transfusion in emergency settings. Their capabilities have gone rapid advancements on the back of incorporation of sensor technology.

Serologic testing has been popularly used in the blood group typing market. However, in recent years, molecular typing methods are gaining preference due to their capability in advanced blood group typing, such as for predicting the probable antigen type.

Antibody Screening Test Segment to Rise From Demand in Low- and Middle-Income Countries

Of the various test types, the antibody screening test segment is anticipated to hold leading share of global blood group typing market by 2026-end. The segment is projected to clock a CAGR more than 10.0% during 2018 - 2026. In low- and middle-income countries, rise in incidence of transfusion transmitted infections (TTIs) has spurred the demand.

HLA typing and antigen segments jointly accounted for approximately 30.0% share of the global blood group typing market in 2017 in revenues.

Various end-use segments are hospitals, clinical laboratories, and blood bank. Of these, hospitals accounted for the top share. The segment is expected to rise at CAGR of 10% during 2018 - 2026. By the end of the period, it is expected to gain some market shares. Widespread demand for various test types makes the segment highly lucrative for market players.

North America Held the Top Share

The various regional markets for blood group typing are North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Of these, North America is the leading segment and is expected to gain share. A great deal of fillip for the uptick in demand for various types of blood group typing comes from active and voluntary blood donors in the U.S. Also, rapid strides have been made by life-saving transfusion medicine, paving way for new avenues for prenatal patients.

Rise in number of blood donors in Asia Pacific has spurred the demand for blood group typing. China is expected to a lucrative market and will rise at an impressive growth rate during 2018 – 2026.

Top players profiled in the report are Grifols, S.A., Bio-Red Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., eckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., and  Novacyt Group.

Blood Group Typing Market - Overview

This report studies the current as well as future prospects of the global blood group typing market. Stakeholders of this report include companies and intermediaries engaged in the manufacture, commercialization, and provision of products for blood group typing and new players planning to enter the market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered in the scope of the study. This section also provides the overall information and data analysis of the global blood group typing market with respect to the leading segments based on product, technique, test, end-user, and region.

Based on product, the global blood group typing market has been categorized into instruments [automated, semi-automated, and manual], consumables (reagent, test kits, antisera, others) and services. In terms of technique, the market has been classified into PCR-based, microarray-based, assay-based technique, and massively parallel technique. Based on test, the market has been segregated into antibody screening, HLA typing, ABO blood test, cross matching test, and antigen typing. Based on end-user, the global blood group typing market has been divided into hospitals, clinical laboratories, blood bank, and others.

Each of the segments has been extensively analyzed based on market related factors such as incidence and prevalence of major chronic diseases. Moreover, historical year-on-year growth has been taken into consideration while estimating the market size. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2016 to 2026. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2018 to 2026, considering 2017 as the base year.

The overview section of the report analyzes market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the blood group typing market and is likely to influence the market in the near future. Market attractiveness analysis has been provided in the overview section in order to explain the intensity of competition in the market across different regions. The competitive scenario among different market players has been evaluated through market share analysis in the competitive landscape section of the report. All these factors are expected to help market players take strategic decisions in order to strengthen their positions and expand their shares in the global blood group typing market.

In terms of geography, the global blood group typing market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2016 to 2026, along with their respective CAGRs for the forecast period from 2018 to 2026, considering 2017 as the base year. The report also provides the market size and forecast for major countries in the respective regions. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s Five Forces analysis, and market share Analysis, by key players, thereby presenting a thorough analysis of the overall competitive scenario in the global blood group typing market.

Key players operating in the global blood group typing market include Grifols, S. A., Bio-Rad Laboratories, Inc., Merck KGaA, Ortho Clinical Diagnostics, QUOTIENT LIMITED, BAG Health Care GmbH, Immucor, Inc., Beckman Coulter, Inc. (Danaher Corporation), Agena Bioscience, Inc., Rapid Labs Ltd, and Novacyt Group.

The global blood group typing market has been segmented as follows:

by Product

  • Instruments
    • Automated
    • Semi-automated
    • Manual
  • Consumables
    • Reagents
    • Test Kits
    • Antisera
    • Others
  • Services

by Technique

  • PCR-based
  • Microarray-based
  • Assay-based Technique
  • Massively Parallel Technique
  •  

by Test

  • Antibody Screening
  • HLA Typing
  • ABO Blood Test
  • Cross Matching Test
  • Antigen Typing

by End-user

  • Hospitals
  • Clinical Laboratories
  • Blood Bank
  • Others

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • Spain
    • U.K.
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Blood Group Typing Market 2018 2026

Buy Now